Nandrolone Phenylpropionate 100 - Somatrop-Lab

Injectable anabolic steroid Nandrolone phenylpropionate is well known for enhancing strength and encouraging the development of muscle mass. Launched in 1957 under the brand name Durabolin by Organon (now Merck/MSD), it has expanded its therapeutic uses over time. Originally prescribed for issues like postoperative lean mass retention and osteoporosis, it is now mainly indicated for advanced metastatic breast cancer and osteoporosis in older patients. Its positive reputation makes it a popular choice, for athletes and bodybuilders seeking to improve performance without experiencing androgenic or estrogenic side effects. Additionally it is beneficial for treating a variety of conditions like severe injuries and specific forms of anemia. showing its flexibility, for both sports and medical uses.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Nandrolone Phenylpropionate 100 by Somatrop-Lab, consult with your doctor or healthcare professional.